All Policies Include Coronavirus Cover
Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30
Coronavirus FAQs
Questions about cover for coronavirus? Read our FAQs and find out what our policies can do for you. If you would like to contact us, please note we are currently only available 09:00 to 17:30 Monday to Friday due to reduced operational capacity. Thank you.
17 November 2017 09:18
It's estimated 8,000 women could benefit from the drugs
Women diagnosed with untreatable breast cancer are being given fresh hope, with the approval of two new "breakthrough" medicines for widespread use across England's health service.
The National Institute for Health and Care Excellence (Nice) has approved NHS use of palbociclib and ribociclib - drugs that are shown to slow down advance cancer and delay the need for chemotherapy.
Nice - which has rejected palbociclib in the past because of its high cost - has announced the new agreement after negotiating a new lower price with manufactured Pfizer.
A life-changing breakthrough
Around 45,000 women receive new diagnoses of breast cancer each year in England, and it's estimated 8,000 women could benefit from the ground-breaking treatment.
Nicholas Turner, trial lead and professor of molecular oncology at the Institute of Cancer Research (ICR) in London and consultant medical oncologist at the Royal Marsden, says: "The development of this brand new class of cancer drug is one of the most important breakthroughs for women with advanced breast cancer in the last two decades.
"In clinical trials, palbociclib and ribociclib have made a huge difference to women's lives - slowing down tumour growth for nearly a year, and delaying the need for chemotherapy with all its potentially debilitating side-effects. These drugs have allowed women to live a normal life for longer."
Treatment for women of any age
Women who are pre-menopausal and have been diagnosed with oestrogen receptor positive breast cancer after it the disease has spread will be eligible for palbociclib.
Post-menopausal women diagnosed who are diagnosed under the same conditions will be treated with ribociclib, manufactured by Novartis.
Both drugs work in a similar way, and are shown to hold back breast cancer for at least 10 months, affording women a normal life for longer.
Even if your cancer has spread, if you have had chemotherapy in the last three months, are taking strong painkillers or have a terminal prognosis, we may still be able to cover you for holidays and overseas travel with our specialist cancer travel insurance.
17 March 2020
Escape it all with a visit to one of the world's hidden island gems.
[more...]
02 July 2021
It's time for some Mediterranean sun and unforgettable sights. Here are five of our favourite must-sees in Malta.
Take your pick of the best beaches in Portugal, spanning more than 500 miles of the Portuguese coastline.
Holidays are back but not quite as we know them. Here's a quick guide to what to expect when travelling to and from green list countries.
28 February 2020
From tulip-filled trips to rose-tinged rests, these destinations are the perfect way to see in the new season.
04 January 2021
Join us on a journey to Ancient Greece to discover more about history's most revered statue.
Head north for a light show like no other. Discover how you can see the Northern Lights for yourself.
Discover more about the magnificent waterfall perched on the border of Zambia and Zimbabwe.
10 December 2020
Don't sleep on the world's most impressive dormant volcano.
A destination that stands head and shoulders above the rest.
19 November 2020
Take a tour of one of South America's most captivating natural landscapes.
Discover the hidden depths of the world's most recognisable desert gorge.